KR20170137566A - THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA - Google Patents
THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA Download PDFInfo
- Publication number
- KR20170137566A KR20170137566A KR1020160069877A KR20160069877A KR20170137566A KR 20170137566 A KR20170137566 A KR 20170137566A KR 1020160069877 A KR1020160069877 A KR 1020160069877A KR 20160069877 A KR20160069877 A KR 20160069877A KR 20170137566 A KR20170137566 A KR 20170137566A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- goat
- fermentation
- content
- lactic acid
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 159
- 230000004151 fermentation Effects 0.000 title claims abstract description 159
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 133
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 120
- 239000004310 lactic acid Substances 0.000 title claims abstract description 60
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 60
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 34
- 230000001965 increasing effect Effects 0.000 title claims abstract description 19
- 240000004371 Panax ginseng Species 0.000 title claims description 132
- 241000894006 Bacteria Species 0.000 title claims description 53
- 238000004519 manufacturing process Methods 0.000 title description 9
- 235000002789 Panax ginseng Nutrition 0.000 title description 6
- 150000001875 compounds Chemical class 0.000 title description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 131
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 131
- 229930182494 ginsenoside Natural products 0.000 claims abstract description 43
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 17
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 241000283707 Capra Species 0.000 claims description 128
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 50
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 50
- 239000012141 concentrate Substances 0.000 claims description 16
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 14
- 235000020710 ginseng extract Nutrition 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 235000014360 Punica granatum Nutrition 0.000 claims description 4
- 244000294611 Punica granatum Species 0.000 claims description 4
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 4
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 4
- 239000006872 mrs medium Substances 0.000 claims description 4
- 244000099147 Ananas comosus Species 0.000 claims description 3
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- 235000004936 Bromus mango Nutrition 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 235000002767 Daucus carota Nutrition 0.000 claims description 3
- 244000000626 Daucus carota Species 0.000 claims description 3
- 235000011511 Diospyros Nutrition 0.000 claims description 3
- 244000236655 Diospyros kaki Species 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 241000220225 Malus Species 0.000 claims description 3
- 235000011430 Malus pumila Nutrition 0.000 claims description 3
- 235000015103 Malus silvestris Nutrition 0.000 claims description 3
- 235000014826 Mangifera indica Nutrition 0.000 claims description 3
- 240000007228 Mangifera indica Species 0.000 claims description 3
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 3
- 235000014443 Pyrus communis Nutrition 0.000 claims description 3
- 240000001987 Pyrus communis Species 0.000 claims description 3
- 235000017848 Rubus fruticosus Nutrition 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 235000009184 Spondias indica Nutrition 0.000 claims description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 3
- 240000006365 Vitis vinifera Species 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- 235000021029 blackberry Nutrition 0.000 claims description 3
- 235000021014 blueberries Nutrition 0.000 claims description 3
- 229940107131 ginseng root Drugs 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 241000167854 Bourreria succulenta Species 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 240000001890 Ribes hudsonianum Species 0.000 claims description 2
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 2
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 235000019693 cherries Nutrition 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 235000013322 soy milk Nutrition 0.000 claims description 2
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 241000208340 Araliaceae Species 0.000 abstract 3
- 239000000047 product Substances 0.000 description 29
- 230000000694 effects Effects 0.000 description 27
- 230000002292 Radical scavenging effect Effects 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 25
- 230000004044 response Effects 0.000 description 24
- 229940089161 ginsenoside Drugs 0.000 description 23
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 21
- 229930182490 saponin Natural products 0.000 description 21
- 150000007949 saponins Chemical class 0.000 description 21
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 15
- 230000002000 scavenging effect Effects 0.000 description 15
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 14
- 239000000284 extract Substances 0.000 description 14
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 13
- 150000002989 phenols Chemical class 0.000 description 13
- 229920001542 oligosaccharide Polymers 0.000 description 11
- 150000002482 oligosaccharides Chemical class 0.000 description 11
- RAQNTCRNSXYLAH-RFCGZQMISA-N (20S)-ginsenoside Rh1 Chemical compound O([C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RAQNTCRNSXYLAH-RFCGZQMISA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- FVIZARNDLVOMSU-IRFFNABBSA-N ginsenoside C-K Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FVIZARNDLVOMSU-IRFFNABBSA-N 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 8
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 8
- 102000006995 beta-Glucosidase Human genes 0.000 description 8
- 108010047754 beta-Glucosidase Proteins 0.000 description 8
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 8
- 229940093496 esculin Drugs 0.000 description 8
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000011449 brick Substances 0.000 description 6
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 235000020251 goat milk Nutrition 0.000 description 5
- 229940039696 lactobacillus Drugs 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000000611 regression analysis Methods 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000675108 Citrus tangerina Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000012004 Ghrelin Human genes 0.000 description 2
- 101800001586 Ghrelin Proteins 0.000 description 2
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside RG2 Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 2
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 2
- RAQNTCRNSXYLAH-UHFFFAOYSA-N Ginsenoside Rh1 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(C3)C)(C)C1C(O)CC2C1(C)CCC(O)C(C)(C)C1C3OC1OC(CO)C(O)C(O)C1O RAQNTCRNSXYLAH-UHFFFAOYSA-N 0.000 description 2
- 206010027146 Melanoderma Diseases 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 150000008495 β-glucosides Chemical class 0.000 description 2
- AGBCLJAHARWNLA-UHFFFAOYSA-N (20R)-ginsenoside Rg2 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C3C(C)(C)C(O)CCC3(C)C3C(C4(CCC(C4C(O)C3)C(C)(O)CCC=C(C)C)C)(C)C2)OC(CO)C(O)C1O AGBCLJAHARWNLA-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 description 1
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 244000172809 Leuconostoc cremoris Species 0.000 description 1
- 235000017632 Leuconostoc cremoris Nutrition 0.000 description 1
- 241001468194 Leuconostoc mesenteroides subsp. dextranicum Species 0.000 description 1
- 241000406209 Leuconostoc mesenteroides subsp. suionicum Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000044283 Toxicodendron succedaneum Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010565 inoculated fermentation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- -1 phenol compound Chemical class 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010993 response surface methodology Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/31—Leuconostoc
- A23V2400/321—Mesenteroides
-
- A23Y2260/35—
Abstract
Description
본 발명은 항산화 효능과 진세노사이드 중 특정의 진세노이드 Rg3, Rh1 및 컴파운드 K (Compound K)의 함량이 증강이 있는 산양삼 유산균 발효물의 제조방법에 관한 것으로, 더욱 구체적으로는 산양삼 추출물을 발효에 적합한 조건으로 조성한 다음 본 기술에 유효한 균주로 분리한 유산균 루코노스톡 멘센테로이데스(Leuconostoc mesenteroises) DU-B1604(KCTC 13015BP)를 전배양하여 접종하고 발효시킨 발효물을 조성하여 최적의 조건에서 항산화 효능과 Rg3, Rh1 및 Compound K의 함량이 증강된 기능성 식품으로 활용할 수 있도록 한 항산화 효능 및 특정의 진세노사이드의 증강이 있는 산양삼 유산균 발효물의 제조방법에 관한 것이다.The present invention relates to a method for preparing a fermented product of Lactobacillus acidus having antioxidant activity and a specific increase in the content of ginsenosides Rg3, Rh1 and Compound K among ginsenosides, and more specifically, ( Leuconostoc mesenteroises ) DU-B1604 (KCTC 13015BP), which had been separated into strains effective for the present technology, were inoculated and fermented in an appropriate condition. And a method for producing fermented product of lactic acid fermented soybean ginseng with specific antioxidative effect and specific ginsenoside enhancement so that the content of Rg3, Rh1 and Compound K can be utilized as functional food having enhanced contents.
일반적으로 산양삼(Korean panax ginseng)은 야생상태에서 자연 발아하여 성장한 천연산삼의 종자나 묘삼을 인위적으로 산삼의 생육환경에 최대한 가깝게 깊은 산속 박달나무, 옻나무 등에 그늘지고 습기가 많은 곳에 뿌려두고 자연 환경에 그대로 방치해 두었다가 수년에서 수십 년이 경과한 후에야 캐내는 삼을 말하나 산양삼에 대한 정확한 정의는 명확하지 않은 상태이다. 산양삼은 다른 말로 장뇌삼, 장로, 장뇌산삼이라고도 하며 뿌리의 굵기와 길이, 몸통의 태 존재 유무, 연령에 따른 뇌두의 개수 그리고 토양과 기후조건에 따라 수명이 다르며, 인삼에 비해 향기가 강하다고 한다. 일단 인삼과 산양산삼의 성분 분석 결과에 따르면 진세노사이드 Rh1, Rg3의 경우 인삼에 없으나 산양산삼에는 일부 소량 검출되었으며, 진세노사이드 모든 성분과 비교했을 때 인삼에 비해 산양산삼의 함량이 높은 것으로 분석된 보고가 있다. 이로 인해 산양삼은 시장 경쟁력에 있어 포화상태인 인삼시장에 비해 효능 및 시장성에 있어 뛰어난 고부가가치를 지니고 대체 소재 및 상품성이 있는 것으로 사료되며 이 산양삼을 발효시키면 Rg1, Rb1, Rg3가 크게 증가하여 약리효과가 증가한다고 보고된바 있다. 가격은 인삼에 비해 10배 이상 비싸지만 발효공정을 통해 약리효능을 높임으로써 기존 인삼시장에서 경쟁력이 있을 것으로 예상된다. 산양삼과 천연삼삼을 비교해보면, 외관은 천연 산삼과 유사하지만 가격은 1/5에서 1/10에 불과하다. 하지만 약리효능은 천연산삼과 유사하다고 인정받고 있으며, 항암, 혈압강하, 항산화, 간독성, 지질강화 등에 효능이 있는 것으로 알려지고 있지만 아직까지 다양한 분야에서의 연구가 미비한 상황이다.In general, Korean panax ginseng is produced by natural ginseng seeds and seedlings grown by natural germination in the wild, artificially sprayed in shady and humid places such as birch trees and lacquer trees deep in the mountains as closely as possible to the growth environment of wild ginseng. After a few years or decades have passed, the exact definition of goose ginseng is unclear. In other words, goat ginseng is also known as ginseng, elder, and camphor ginseng, and its lifespan is different according to the thickness and length of roots, the presence of ginseng in the trunk, the number of ginseng according to age, and soil and climatic conditions. According to the results of analysis of ginseng and ginseng root ginseng, ginsenosides Rh1 and Rg3 were not found in ginseng but only a small amount was detected in ginseng ginseng. Compared to all ginsenosides, ginseng ginseng content was higher than ginseng There is a report. As a result, it is believed that goat ginseng has high value added in terms of efficacy and marketability compared to saturated ginseng market in market competitiveness, and it is considered to have substitute material and commerciality. When fermenting this goat ginseng, Rg1, Rb1 and Rg3 are greatly increased, Of the patients. Although the price is more than 10 times higher than that of ginseng, it is expected to be competitive in the existing ginseng market by enhancing pharmacological efficacy through fermentation process. Compared to native ginseng and natural ginseng, appearance is similar to that of natural ginseng, but prices are only 1/5 to 1/10. However, pharmacological efficacy is considered to be similar to natural ginseng, and it is known to be effective against anticancer, hypotensive, antioxidant, hepatotoxicity and lipid strengthening.
인삼류에 포함된 사포닌을 진세노사이드(ginsenoside)라고 하며, 비누를 뜻하는 사포나(sapona)에서 유래되었으며 수용액에서 거품을 내서 붙여진 이름이다. 한약방에서 강심제, 이뇨제로 사용되었으며 식물의 뿌리, 줄기, 잎, 껍질 등에 포함되어있고 항암, 항산화 작용으로 다른 식물과는 다른 약리작용을 하고 있으며 특이한 화학구조를 가지고 있어서 화장품, 기능성 식품으로 널리 이용되고 있다. 인삼류에서 진세노사이드, 폴리아세틸렌(polyacetylene), 산성 다당체, 인삼 단백질, 페놀성 물질 등의 성분들이 밝혀졌고 이들 중에서 진세노사이드는 그 화학구조가 명확히 확인되었다. 또한 항당뇨 활성을 비롯하여 항암작용, 항산화작용, 동맥경화 및 고혈압의 예방, 간 기능 촉진 및 숙취제거효과, 항 피로 및 항 스트레스 작용, 노화방지 작용, 두뇌활동 촉진작용, 항염증활성, 알레르기성 질환치료, 단백질합성의 촉진 등의 작용이 보고되고 있다. 특히, 수삼을 쩌서 건조한 홍삼은 열에 의해서 생성되는 홍삼 특유성분인 진세노사이드 Rg2, Rg3, Rh1, Rh2 등이 암 예방작용, 암세포 성장 억제작용, 혈압강하작용, 뇌신경세포 보호작용, 항혈전작용, 항산화작용이 있다고 하여 홍삼만의 특장점으로 주목받고 있다.The saponin contained in ginseng is called ginsenoside. It is derived from sapona (soap) and is bubbled in aqueous solution. It is used as a cardiovascular and diuretic in the herbal medicine. It is contained in the roots, stem, leaves and bark of plants. It has anti-cancer and antioxidant effects and has a different pharmacological effect from other plants. It has a unique chemical structure and is widely used as a cosmetic and functional food have. In ginseng, ginsenoside, polyacetylene, acid polysaccharide, ginseng protein and phenolic substance were identified, and the chemical structure of ginsenoside was clearly confirmed. In addition, it has antidiabetic activity as well as anticancer activity, antioxidant activity, prevention of arteriosclerosis and hypertension, promotion of hepatic function and elimination of hangover, anti-fatigue and anti-stress action, anti-aging action, brain activity acceleration action, anti- Treatment, promotion of protein synthesis, etc. have been reported. In particular, red ginseng dried with fresh ginseng is known as a ginsenoside Rg2, Rg3, Rh1, and Rh2, which is a specific component of red ginseng produced by heat, has functions of preventing cancer, inhibiting cancer cell growth, hypotensive action, Since it has antioxidant activity, it is attracting attention as a special feature of red ginseng.
유산균은 인간이 이용할 수 있는 가장 유익한 미생물 중의 한 종류로서, 비병원성균으로 인간의 장내에 서식하면서 정장 및 정균작용을 할 수 있고 당류를 발효해서 다량의 젖산을 생성하고 낮은 pH 및 혐기적인 조건에서도 잘 생육하며 여러 가지 영양물질을 요구하는 등의 특징을 가지고 있다. 유산균에 의해 채소류가 발효되면 독특한 향과 맛을 내게 되어 관능적 특성이 향상되고, 유기산에 의하여 비타민 C(vitamin C)와 여러 생리활성물질이 잘 보존되며, 초기 재료에는 거의 존재하지 않았던 비타민 B12와 비타민 K가 생합성되어 부패균과 병원성균의 성장과 증식을 저해하여 위생적인 식품이 되는 등의 장점을 가지고 있는 것으로 알려져 있다. Lactic acid bacteria is one of the most beneficial microorganisms that can be used by humans. It is a non-pathogenic bacterium that can function in the intestines of humans and can function as a bacterium and bacterium. It ferments sugars to produce a large amount of lactic acid. And it requires a variety of nutrients. When vegetables are fermented by lactic acid bacteria, their flavor and taste are enhanced, and their sensory characteristics are improved. Vitamin C (vitamin C) and various physiologically active substances are well preserved by organic acids. Vitamin B12 and vitamins It is known that K is biosynthesized and inhibits the growth and proliferation of spoilage bacteria and pathogenic bacteria, and becomes a hygienic food.
본 발명과 관련된 선행기술로는 대한민국 등록특허 10-1133739호가 공지되어 있으나 이는 백삼 추출물을 산가수분해 열처리함으로써 Rg3 함량이 높은 백삼 추출물의 제조방법과 이로부터 제조된 진세노이드 Rg3 함량이 높은 백삼 추출물에 관한 것이고, 대한민국 등록특허 10-1401658호에 진세노사이드 컴파운드 K 또는 이의 유도체로 된 항균제에 관한 것이 공지되어 있다. 그러나 현재까지 항산화효능과 Rg3, Rh1 및 컴파운드 K의 함량이 증강이 있는 산양삼 유산균 발효물의 제조방법에 대하여는 공지된 바 없다.Korean Patent No. 10-1133739 discloses a prior art related to the present invention. However, the present invention relates to a method for producing white ginseng extract having a high Rg 3 content by heat hydrolysis of white ginseng extract and white ginseng extract prepared from the ginsenoside Rg 3 And Korean Patent No. 10-1401658 discloses an antimicrobial agent comprising a ginsenoside compound K or a derivative thereof. However, there is no known method for producing the fermented product of L. acidophilus with antioxidant activity and increased content of Rg 3 , Rh 1 and Compound K until now.
본 발명의 목적은 Rg3, Rh1 및 컴파운드 K 함량이 강화된 산양삼 발효물의 제조방법 및 그 발효물을 제공하는데 있다.It is an object of the present invention to provide a method for producing a fermented goat ginseng having enhanced Rg 3 , Rh 1 and compound K contents and a fermented product thereof.
본 발명은 상기 방법에 따라 제조되어 진세노사이드 Rg3, Rh1 및 컴파운드 K 함량이 강화된 산양삼 발효물이 함유된 건강기능성 식품을 제공하는데 있다.The present invention is to provide a health functional food prepared according to the above method and containing a fermented goat ginseng having enhanced ginsenoside Rg 3 , Rh 1 and compound K content.
본 발명의 상기 목적은 산양삼 추출물을 이용한 유산균 발효물의 제조방법에 있어서 산양삼을 분쇄하여 특정의 조건(75℃, 5시간 30분)에서 추출한 15 브릭스(°brix)의 산양삼 추출물을 회전농축기를 이용하여 50 ℃의 수조에서 20~50 브릭스로 농축하는 1단계(S1)와; 상기 단계(S1)에서 얻은 산양삼 농축액을 전체부피의 1~50 부피%로 조정하여 첨가하는 제2단계(S2)와; 상기 단계에서 얻은 전체부피에 갈락토올리고당(galactooligosaccharide)을 0.1~30 부피%를 첨가하고 pH를 5.0~7.0으로 조정한 후 살균 처리하는 제3단계(S3)와; 상기 단계에서 살균 처리된 산양삼 조성액에 상업용 MRS배지에 전배양한 분리 유산균 루코노스톡 메센테로이데스(Leuconostoc mesenteroides) DU-B1604(KCTC 13015BP)을 산양삼 조성액의 0.1~20 부피%를 접종하는 제4단계(S4)와; 상기 단계에서 얻은 유산균이 접종된 조성액을 발효온도 20~45℃, 발효시간 6~120 시간을 발효하는 제5단계(S5)로 이루어지고 항산화 효능과 Rg3, Rh1 및 컴파운드 K 등 특정의 진세노이드 함량을 평가함으로써 달성하였다.The above object of the present invention is achieved by a method for producing fermented lactic acid bacteria using a goat's ginseng extract, which comprises grinding the goat's ginseng and extracting 15 brix of the goat ginseng extracted at a predetermined condition (75 DEG C, 5 hours and 30 minutes) A first step (S1) of concentrating the water in a water bath at 50 DEG C to 20-50 bricks; A second step (S2) of adjusting the goat ginseng concentrate obtained in the step (S1) to 1 to 50 volume% of the total volume and adding the same; A third step (S3) of adding 0.1 to 30% by volume of galactooligosaccharide to the total volume obtained in the above step and adjusting the pH to 5.0 to 7.0 and then sterilizing the mixture; In the above-mentioned step, the ginseng root-treated ginseng was added to a commercially available MRS medium, which had been pre-cultured, and the separated lactic acid bacteria, Leuconostoc mesenteroides ) DU-B1604 (KCTC 13015BP) in 0.1 to 20% by volume of the composition of the goat's ginseng; The composition liquid is lactic acid obtained in Step The inoculated
본 발명은 필요에 따라 상기 제5단계(S5)에서 얻은 산양삼 발효물은 살균온도 60~100℃에서 10~60분간 가열 살균 처리한 후 1.0 마이크로 필터 여과기를 통과시켜 여과하는 제6단계(S6)를 더 포함할 수 있다.In the present invention, the fermented goat germ obtained in the fifth step (S5) is sterilized at a sterilization temperature of 60 to 100 DEG C for 10 to 60 minutes and then filtered through a microfilter filter (S6) As shown in FIG.
상기 제1단계에서의 액상의 산양삼 추출물은 산양삼 분쇄액, 산양삼추출액, 산양삼농축액, 산양삼 건조물 및 산양삼 과립 중에서 선택되는 어느 하나 이상을 사용하여 제조되는 것을 특징으로 한다.The liquid goat's ginseng extract in the first step is prepared by using at least one selected from the group consisting of a goat's grind liquid, a goat ginseng extract, a goat ginseng concentrate, a dried goat ginseng product and a goat ginseng granule.
상기 제3단계에서의 갈락토올리고당(galactooligosaccharide)은 이 밖에도 말토올리고당(maltooligosaccharide), 프락토올리고당(fructooligosaccharide) 및 이소말토올리고당(isomaltooligosaccharide) 중에서 선택되는 어느 하나이상을 사용하여 제조되는 것을 특징으로 한다. The galactooligosaccharide in the third step is further characterized by being prepared using at least one selected from maltooligosaccharide, fructooligosaccharide and isomaltooligosaccharide.
상기 제5단계에서 얻은 발효물 또는 제6단계에서 얻은 살균 여과된 발효물 0.1~99.9 중량 또는 부피부에 맛의 향상을 위하여 사과, 감, 블루베리, 블랙베리, 블랙커런트, 아사이베리, 복분자, 석류, 포도, 배, 복숭아, 바나나, 딸기, 토마토, 당근, 자두, 매실, 앵두, 다래, 오디, 머루, 키위, 참외, 귤, 오렌지, 자몽, 귤, 멜론, 체리, 멜론, 블랙수퍼베리, 망고, 레몬, 파인애플로 된 원료과실, 착즙액 또는 농축액으로 이루어진 군으로부터 선택되는 어느 하나 이상을 0.1~99.9중량 또는 부피부를 추가로 더 첨가하는 것을 특징으로 한다.The fermented product obtained in the fifth step or the sterilized and filtered fermented product obtained in the sixth step may be added in an amount of 0.1 to 99.9 wt% or in order to improve the taste of the poultice, apple, persimmon, blueberry, blackberry, black currant, Pomegranate, grape, pear, peach, banana, strawberry, tomato, carrot, plum, plum, cherry, A raw material fruit made of mango, lemon, pineapple, a juice or a concentrated liquid is further added in an amount of 0.1 to 99.9 parts by weight or more.
본 발명에 따라 제조된 산양삼의 유산균 발효물은 항산화 효능과 인삼과 홍삼의 보편적인 진세노사이드 이외에도 특히 진세노사이드인 Rg3, Rh1 및 컴파운드 K의 함량이 증강되어 건강 기능성 식품을 제공할 수 있는 뛰어난 효과가 있다.The lactic acid fermented product of the goat ginseng prepared according to the present invention has antioxidant activity and the content of ginsenosides Rg 3 , Rh 1 and Compound K in addition to the common ginsenosides of ginseng and red ginseng, There is an excellent effect.
도1은 본 발명에 따른 항산화 효능 및 특정의 진세노사이드인 Rg3, Rh1 및 컴파운드 K의 함량이 증강된 산양삼의 유산균 발효물 제조방법을 단계별로 나타낸 다이어그램이다.
도2는 본 발명에서 공시재료로 사용한 1차분리된 유산균들(균주번호 25~29)의 에스큘린 배지에서 에스큘린 반응사진도이다.
도3은 본 발명에 따른 표준균주와 최종분리균주 L1(붉은색)의 16S rRNA 유전자 시퀸스 기반으로 한 계통수(phylogenetic tree)의 근연관계도이다.
도4는 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 pH(pH : 3.40 - 3.55 - 3.70)변화에 대한 4차원 반응표면을 보인 그래프이다.
도5는 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 산도(acidity : 0.4 - 0.6 - 0.8 %)변화에 대한 4차원 반응표면을 보인 그래프이다.
도6은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 유산균생균수 (viable cell content : 13.0 - 13.5 - 14.0 Log CFU/mL)변화에 대한 4차원 반응표면을 보인 그래프다.
도7은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 조사포닌 함량 (crude saponin content : 0.1 - 0.2 - 0.3%)변화에 대한 4차원 반응표면을 보인 그래프이다.
도8은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 총페놀화합물 함량(total phenolics compound content : 70 - 75 - 80 mg%)변화에 대한 4차원 반응표면을 보인 그래프다.
도9는 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 DPPH 라디칼 소거능(DPPH radical scavenging activity : 55 - 60 - 65%)변화에 대한 4차원 반응표면을 보인 그래프다.
도10은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 ABTS 라디칼 소거능(ABTS radical scavenging activity : 52 - 55 - 58%) 변화에 대한 4차원 반응표면을 보인 그래프다.
도11은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 아질산염 소거능(nitrate scavenging activity : 35 - 40 - 45%) 변화에 대한 4차원 반응표면을 보인 그래프다.
도12는 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 총페놀화합물 함량, 총사포닌함량 및 DPPH 라디칼 소거능의 최적조건에 대한 4차원 반응표면의 다중겹침도를 보인 그래프다.
도13은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 진세노사이드 Rg1 함량(ginsenoside Rg1 content : 3.5 - 4.5 - 5.5 mg%)변화에 대한 4차원 반응표면을 보인 그래프다.
도14는 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 진세노사이드 Rb1 함량(ginsenoside Rb1 content : 16 - 19 - 22 mg%)변화에 대한 4차원 반응표면을 보인 그래프다.
도15는 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 진세노사이드 Rh1 함량(ginsenoside Rh1 content : 2.7 - 3.2 - 3.7 mg%)변화에 대한 4차원 반응표면을 보인 그래프다.
도16은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 진세노사이드 Rg3 함량(ginsenoside Rg3 content : 4.0 - 4.5 - 5.0 mg%)변화에 대한 4차원 반응표면을 보인 그래프다.
도17은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 진세노사이드 컴파운드 K 함량(ginsenoside compound K content : 3 - 5 - 7 mg%)변화에 대한 4차원 반응표면을 보인 그래프다.
도18은 본 발명 산양삼농도, 갈락토 올리고당 농도 및 시간 조건에 따른 산양삼 발효믈의 진세노사이드 Rh1, 진세노사이드 Rg3와 컴파운드 K 최대함량을 위한 최적조건에 대한 4차원 반응표면의 다중겹침도를 보인 그래프다.
도19는 본 발명에 따른 발효전 배양물의 진세노사이드 크로마토그램이다.
도20은 본 발명에 따른 진세노사이드 함량을 위한 최적발효조건에서 발효한 배양물의 진세노사이드 크로마토그램이다. FIG. 1 is a diagram showing a stepwise process for preparing a fermented product of Lactobacillus acidus according to the present invention, in which the content of Rg 3 , Rh 1 and Compound K, which are antioxidant and specific ginsenosides, is enhanced.
Fig. 2 is a photograph of esculin reaction in an Escherichia culture medium of primary isolated lactic acid bacteria (strain No. 25 to 29) used as a publicly-known material in the present invention.
Figure 3 is a close relational diagram of a phylogenetic tree based on the 16S rRNA gene sequence of the standard strain according to the invention and the final isolate L1 (red).
FIG. 4 is a graph showing the four-dimensional reaction surface of the pH (pH: 3.40 - 3.55 - 3.70) change of the goat ginseng fermentation product according to the present invention ginseng concentration, galactooligosaccharide concentration and time condition.
FIG. 5 is a graph showing the 4-dimensional response surface of the acidity (0.4 - 0.6 - 0.8%) change of the goat's ginseng fermentation product according to the present invention ginseng concentration, galactooligosaccharide concentration and time condition.
FIG. 6 is a graph showing the 4-dimensional response surface of viable cell content (13.0 - 13.5 - 14.0 Log CFU / mL) of the goat's germ fermented product according to the inventive ginseng concentration, galactooligosaccharide concentration and time condition .
FIG. 7 is a graph showing a 4-dimensional reaction surface for crude saponin content (crude saponin content: 0.1-0.2-0.3%) of the goat's milk fermented product according to the present invention's concentration, galactooligosaccharide concentration and time conditions.
FIG. 8 is a graph showing the 4-dimensional response surface of the total phenolics compound content (70 - 75 - 80 mg%) of the goat fermented product according to the present invention, the concentration of galactooligosaccharide and time conditions .
FIG. 9 is a graph showing the 4-dimensional response surface of the DPPH radical scavenging activity (55 - 60 - 65%) change according to the present invention ginseng concentration, galactooligosaccharide concentration and time conditions.
FIG. 10 is a graph showing the 4-dimensional response surface of the ABTS radical scavenging activity (52 - 55 - 58%) changes according to the present invention ginseng concentration, galactooligosaccharide concentration and time conditions.
FIG. 11 is a graph showing the 4-dimensional response surface of the nitrate scavenging activity (35 - 40 - 45%) of the goat's milk fermentation according to the present invention, the concentration of galactooligosaccharide and time conditions.
FIG. 12 is a graph showing the multiple overlapping of the four-dimensional reaction surface on the optimum conditions of the total phenol compound content, total saponin content and DPPH radical scavenging ability of the goat's ginseng fermented product according to the present invention ginseng concentration, galactooligosaccharide concentration and time condition .
13 is the present invention sanyangsam concentration, galactosyl sanyangsam fermentation sprocket of ginsenoside Rg 1 content according to the oligosaccharide concentration and time conditions: showing a four-dimensional reaction surface for the (ginsenoside Rg 1 content 3.5 - 5.5 mg% - 4.5) Change Graph.
14 is sanyangsam ginsenoside Rb 1 content of the fermentation sprocket according to the invention sanyangsam concentration, galacto-oligosaccharide concentration and time conditions (ginsenoside Rb 1 content: 16 - 19 - 22 mg%) showing a four-dimensional response surface for a change Graph.
15 is the present invention sanyangsam concentration, galacto-oligosaccharide concentration and time conditions sanyangsam ginsenosides Rh 1 content of the fermentation Sprocket according to: showing a four-dimensional reaction surface for the (ginsenoside Rh 1 content 2.7 - 3.7 mg% - 3.2) Change Graph.
16 is the present invention sanyangsam concentration, galacto-oligosaccharide concentrations, and ginsenosides Rg 3 content of sanyangsam fermentation sprocket according to the time condition (ginsenoside Rg 3 content: 4.0 - 4.5 - 5.0 mg%) showing a four-dimensional response surface for a change Graph.
17 shows the 4-dimensional response surface of the ginsenoside compound K content (ginsenoside compound K content: 3 - 5 - 7 mg%) of the goat fermented product according to the present invention ginseng concentration, galactooligosaccharide concentration and time condition Graph.
FIG. 18 is a graph showing the results of multiple overlapping of four-dimensional reaction surfaces for optimal conditions for ginsenoside Rh 1 , ginsenoside Rg 3 and compound K maximum content of goat juice fermentation according to the present invention ginseng concentration, galactooligosaccharide concentration, Fig.
19 is a ginsenoside chromatogram of the pre-fermentation culture according to the present invention.
20 is a ginsenoside chromatogram of a culture fermented under optimal fermentation conditions for ginsenoside content according to the present invention.
이하 본 발명의 바람직한 실시 예를 상세히 설명하면 다음과 같다. Hereinafter, preferred embodiments of the present invention will be described in detail.
본 발명은 산양삼 분쇄액, 산양삼 추출액, 산양삼 농축액, 산양삼 건조물, 산양삼 과립 중 어느 하나 이상이 선택되어 지는 것을 이용하여 만든 액상의 산양삼에 갈락토올리고당을 첨가하여 조성한 후 살균처리하여 전배양한 분리 유산균 루코노스톡 메센테로이데스(Leuconostoc mesenteroides) DU-B1604(KCTC 13015BP)을 접종하여 최적의 발효조건에서 발효시켜 항산화 효능이 있고 특정의 진세노사이드인 Rg3, Rh1 및 컴파운드 K의 함량이 증강된 산양삼의 유산균 발효물의 제조방법에 관한 것이다. The present invention relates to a method for producing a lactic acid bacteria which comprises adding a galactooligosaccharide to a liquid goat's ginseng prepared by using at least one selected from the group consisting of a goat's milk powder, a goat extract, a goat ginseng concentrate, a dried goat ginseng product, Leuconostoc mesenteroides ) DU-B1604 (KCTC 13015BP), fermented under optimal fermentation conditions to obtain antioxidant activity, and the contents of specific ginsenosides Rg 3 , Rh 1 and Compound K were enhanced. .
본 발명에 따르면 산양삼을 분쇄하여 특정의 조건(70% 발효주정, 75℃, 5시간 30분)에서 추출한 산양삼 추출물(15 브릭스)을 회전농축기를 이용하여 수조 50℃에서 추출액중의 주정을 제거하여 20~50 브릭스로 농축하는 1단계(S1)와; 상기 단계에서 얻은 산양삼 농축액을 전체부피의 1~50부피% 로 조정하여 첨가하는 제2단계(S2)와; 상기 단계에서 얻은 전체부피에 갈락토올리고당(galactooligosaccharide)을 0.1~30 부피%를 첨가하고 pH를 5.0~7.0으로 조정한 후 살균 처리하는 제3단계와; 상기 단계에서 살균 처리하여 얻은 산양삼 조성액에 상업용 MRS배지에 전배양한 분리 유산균 루코노스톡 메센테로이데스(Leuconostoc mesenteroides) DU-B1604(KCTC 13015BP)을 산양삼 조성액의 0.1~20 부피%를 접종하는 제4단계와; 상기 단계에서 유산균을 접종한 조성액을 발효온도 20~45℃, 발효시간 6~120 시간을 발효하는 제5단계로 이루어지고 항산화 효능과 특정의 진세노사이드인 Rg3, Rh1 및 컴파운드 K의 함량을 평가하여 산양삼의 유산균 발효물이 첨가된 건강 기능성 식품을 제공함을 특징으로 한다.According to the present invention, the goat's ginseng extract (15 brix) extracted from a predetermined condition (70% fermented alcoholic beverage, 75 ° C, 5 hours and 30 minutes) was pulverized and the alcohol in the extract was removed at 50 ° C in a water bath using a rotary concentrator A first step (S1) of concentrating to 20-50 Bricks; A second step (S2) of adjusting the goat's ghe concentrate obtained in the above step to 1 to 50% by volume of the total volume; A third step of adding 0.1 to 30% by volume of galactooligosaccharide to the total volume obtained in the above step and adjusting the pH to 5.0 to 7.0 and then sterilizing the mixture; In the soymilk composition obtained by the sterilization treatment in the above step, the separated lactic acid bacteria pre-cultured on a commercial MRS medium, Leuconostoc mesenteroides ) DU-B1604 (KCTC 13015BP) in 0.1 to 20% by volume of the composition of the goat's ginseng; Wherein the fermentation is carried out at a fermentation temperature of 20 to 45 ° C. and a fermentation time of 6 to 120 hours. The antioxidative activity of the fermentation broth is determined by measuring the content of Rg 3 , Rh 1 and Compound K To provide a health functional food supplemented with a fermented product of Lactobacillus of the goat's ginseng.
본 발명은 상기 제5단계를 거친 산양삼 발효물은 살균온도 60~100℃에서 10~60분간 가열 살균 처리한 후 1.0 마이크로 필터 여과기를 통과시켜 여과하는 제6단계를 더 포함하는 것을 특징으로 한다.The method of the present invention is further characterized by further comprising a sixth step of subjecting the fermented goat having been subjected to the fifth step to a heat sterilization treatment at a sterilization temperature of 60 to 100 DEG C for 10 to 60 minutes, and then filtering through a 1.0 microfilter filter.
본 발명은 상기 제1단계에서의 액상의 산양삼은 산양삼 분쇄액, 산양삼추출액, 산양삼농축액, 산양삼 건조물 및 산양삼 과립 중에서 선택되는 어느 하나 이상으로 제조되는 것을 특징으로 한다.The present invention is characterized in that the liquid goat's ginseng in the first step is manufactured by any one or more selected from the group consisting of a raw ginseng pulverization solution, a goat ginseng extract solution, a goat ginseng concentrate, a dried goat ginseng product and a goat ginseng granule.
본 발명에 따르면, 상기 3단계에서의 갈락토올리고당(galactooligosaccharide)은 말토올리고당(maltooligosaccharide), 프락토올리고당(fructooligosaccharide) 및 이소말토올리고당(isomaltooligosaccharide) 중에서 선택되는 어느 하나이상을 사용하여 제조되는 것을 특징으로 한다.According to the present invention, the galactooligosaccharide in the step 3 is prepared by using at least one selected from maltooligosaccharide, fructooligosaccharide and isomaltooligosaccharide. do.
본 발명에 따르면, 상기 제5단계를 거친 발효물 또는 제6단계를 거쳐 살균 여과된 발효물 0.1~99.9 중량 또는 부피부에 맛의 향상을 위하여 사과, 감, 블루베리, 블랙베리, 블랙커런트, 아사이베리, 복분자, 석류, 포도, 배, 복숭아, 바나나, 딸기, 토마토, 당근, 자두, 매실, 앵두, 다래, 오디, 머루, 키위, 참외, 귤, 오렌지, 자몽, 귤, 멜론, 체리, 멜론, 블랙수퍼베리, 망고, 레몬, 파인애플로 된 원료과실, 착즙액 또는 농축액으로 이루어진 군으로부터 선택되는 어느 하나 이상의 부원료를 0.1~99.9중량 또는 부피부를 첨가하는 것을 특징으로 한다.According to the present invention, the fermented product after the fifth step or the fermented product sterilized and filtered through the sixth step may be used in an amount of 0.1 to 99.9 wt%, or in order to improve the taste of the poultry, an apple, persimmon, blueberry, blackberry, Pepper, Pomegranate, Pomegranate, Grape, Pear, Peach, Banana, Strawberry, Tomato, Carrot, Plum, Plum, Cherry, Duck, Odyssey, Mulberry, Kiwi, Melon, Tangerine, Orange, Grapefruit, Tangerine, Melon, Cherry, Melon , Black superbary, mango, lemon, pineapple, fruit juice, or concentrate is added in an amount of from 0.1 to 99.9 parts by weight or by weight.
이하, 본 발명의 구체적인 내용을 실시예와 실험예를 통하여 설명하지만 본 발명의 권리 범위가 여기에 기재된 사항에 제한되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples, but the scope of the present invention is not limited thereto.
실시예 1.Example 1.
1) 유산균 분리1) Isolation of lactic acid bacteria
유산균 분리에 사용한 발효식품 시료는 가정집 및 음식점에서 담근 김치 수십 종 및 침채류 등을 수집하여 시료액으로 사용하였으며, 각 시료액을 멸균증류수로 10-1 ~ 10-5으로 희석한 후 0.004% BCP가 첨가된 시판용 MRS 한천배지에 100 μl 씩 분주 도말하고, 37℃에서 24시간 배양 후 나타난 독립된 콜로니 중 유산균의 특징적인 콜로니를 순수 분리하였다. 순수 분리한 유산균은 MRS 한천사면배지에 접종하여 37℃에서 24시간 배양한 후 4℃ 냉장보관하면서 사용하였다.
The fermented food samples used for the isolation of lactic acid bacteria were collected from dozens of kimchi dipped in households and restaurants and used as sample liquids. Each sample liquid was diluted to 10-1 to 10-5 with sterilized distilled water, and 0.004% BCP 100 μl aliquots were added to the commercially available MRS agar medium and cultured for 24 hours at 37 ° C. to isolate characteristic colonies of lactic acid bacteria from isolated colonies. The purely isolated lactic acid bacteria were inoculated on MRS agar slant medium, cultured at 37 ° C for 24 hours, and stored at 4 ° C in a refrigerator.
2) 베타글루코시데이스(β-Glucosidase) 활성 균주 선발2) Selection of β-Glucosidase active strains
베타글루코시데이스 활성을 갖는 균주의 선발을 위해 에스쿨린 한천(esculin 0.1%, peptones 1.8%, ferric citrate 0.1%, agar 2%)법을 이용하여 에스쿨린(esculin)이 함유된 에스쿨린 한천배지에 균주를 접종하여 배지 내에서의 색깔 변화를 관찰하였다(도2). 에스쿨린은 베타글루코시데이스에 의하여 글루코스(glucose) 와 에스쿨린으로 분리 되며 에스쿨린은 ferric ammonium citrate 와 반응하여 콜로니주위에 검은색 반점(black complex)를 형성하게 된다. 따라서 에스쿨린 한천배지에서 배양된 콜로니주위에 검은색 반점를 형성하는 균주를 베타글루코시데이스 활성을 가지는 균주로 판단하여 선별하였다.For the selection of strains having beta-glucosidase activity, Escherin agar medium (esculin 0.1%, peptones 1.8%, ferric citrate 0.1%, agar 2% The strain was inoculated and the change in color in the medium was observed (Fig. 2). Esculin is separated into glucose and esculin by beta glucoside, and esculin reacts with ferric ammonium citrate to form a black complex around the colon. Therefore, strains which form black spots around colonies cultured on Escherichia agar medium were selected as strains having beta glucoside activity.
… [구조식1] ... [Structural formula 1]
3) 베타글루코시데이스(β-Glucosidase) 활성능 측정3) Measurement of β-Glucosidase activity
베타글루코시데이스 활성 측정은 1% 카르복시메칠셀루로스(carboxymethyl cellulose, CMC)가 첨가된 시판용 MRS 배지에 12 시간 전배양한 균주를 접종하여 37℃에서 24 시간 배양 후, 배양액을 4℃에서 3000 rpm으로 15 분간 원심분리하여 세포를 제거하고, 상층액 0.5 ml를 취하여 1 ml의 5 mM ρ-nitrophenyl-β-D-glucopynanoside(ρ-NPG)용액과 혼합한 후 37℃에서 30 분간 반응시켰다. 반응액은 1 ml의 1 M Na2CO3 용액을 첨가하여 반응을 중지시키고, 생성된 p-nitrophenol를 405 nm에서 흡광도를 측정한 후 ρ-NP의 검량곡선을 이용하여 농도를 환산하였다.
The activity of β-glucosidase activity was measured by inoculating a commercially available MRS medium containing 1% carboxymethyl cellulose (CMC) for 12 hours before inoculation, culturing the cells at 37 ° C. for 24 hours, . The cells were removed by centrifugation for 15 minutes. 0.5 ml of the supernatant was mixed with 1 ml of 5 mM ρ-nitrophenyl-β-D-glucopynanoside (ρ-NPG) solution and reacted at 37 ° C for 30 minutes. The reaction was terminated by the addition of 1 ml of 1 M Na2CO3 solution, and the resulting p-nitrophenol was measured for absorbance at 405 nm and the concentration was calculated using a calibration curve of ρ-NP.
4) 최종선별균주의 염기서열분석과 계통분류4) Sequence analysis and phylogeny of the final selection strains
최종 선별된 균주의 16S rRNA gene은 시퀀싱(sequencing) 을 통하여 분석하였으며, NCBI 데이터베이스(database)를 이용하여 분리된 균주와 database상의 표준균주(type strain)와의 유사성(similarity, %)을 확인하였다.
The 16S rRNA gene of the finally selected strain was analyzed by sequencing and the similarity (%) between the isolated strain and the type strain on the database was confirmed using the NCBI database.
실시예 2.Example 2.
1) 산양삼 추출액을 활용한 발효조건 1) Fermentation conditions using goat extract
(1) 산양삼 추출액의 수득(1) Acquisition of goat ginseng extract
산양삼을 흐르는 물에 세척하고 이물질을 제거한 다음 마쇄기로 골고루 마쇄하여 추출에 사용하였다. 마쇄한 산양삼의 추출은 70% 발효주정에 마쇄한 산양삼을 10% 첨가하여 75℃, 5시간 30분에서 추출한 산양삼 추출물에서 15 브릭스의 추출액을 얻었다. 이 추출액을 회전농축기를 이용하여 50 ℃의 항온수조에서 20~50 브릭스로 농축하여 농축액을 수득하였다. 수득되는 산양삼 농축액을 농도 조절하여 발효에 사용하였다.
The goat ginseng was washed with flowing water, and the foreign material was removed, and the mixture was uniformly ground with a grinder to be used for extraction. Extracts of 15 mg of goat ginseng were obtained from the extracts of goat ginseng extracted at 75 ℃ for 5 hours and 30 minutes. This extract was concentrated to 20-50 Bricks in a constant temperature water bath at 50 ° C using a rotary condenser to obtain a concentrate. The obtained goat ginseng concentrate was used for fermentation by controlling its concentration.
(2) 올리고당 첨가 효과 시험(2) Effect test of oligosaccharide addition
산양삼의 효율적인 유산균발효를 위하여 부원료 첨가효과를 조사하였다. 산양삼 농축액(25 브릭스) 5 용량%에 부원료로서 올리고당 종류를 1 용량%를 각각 첨가하여 121℃에서 15분간 가입멸균 후, 전 배양한 분리 유산균주를 2 부피% 접종하여 37℃에서 48시간 발효하여 유산균의 발효능을 조사하였다.
The effects of additives were investigated for efficient lactic acid fermentation. 1% by volume of oligosaccharide was added as a supplement to 5% by volume of goat's ghrelin concentrate (25 brix), sterilized at 121 ° C for 15 minutes, sterilized for 15 minutes and then inoculated with 2% by volume of isolated lactic acid bacteria pre- The efficacy of lactic acid bacteria was investigated.
(3) 조사포닌 함량 측정 (3) Measurement of crude saponin content
추출농축액 및 발효액의 조사포닌 함량은 n-butanol 추출법에 따라 정량하였다. 즉, 추출액 및 발효액 30 ml를 diethyl ether 30 ml로 3회 세척하여 지용성 성분을 제거한 후 수층에 수포화 n-butanol 30 ml를 가하여 3회 분리하고, n-butanol 층을 농축시켜 조사포닌을 얻은 다음 105℃ 건조기에서 항량이 될 때까지 건조하였다. 조사포닌 함량은 사용된 원료 양에 대한 백분율로 나타내었다.
The crude saponin content of the extract concentrate and the fermentation broth was determined by n-butanol extraction method. That is, 30 ml of the extract and the fermentation broth were washed three times with 30 ml of diethyl ether to remove fat-soluble components, 30 ml of water-saturated n-butanol was added to the aqueous layer three times and the n-butanol layer was concentrated to obtain crude saponin And dried in a 105 ° C drier until the weight became constant. The crude saponin content is expressed as a percentage of the amount of raw material used.
(4) 진세노사이드(ginsenoside) 함량 측정(4) Measurement of ginsenoside content
추출농축액 및 발효액의 진세노사이드 조성 및 함량은 조사포닌 추출한 것을 메탄올에 용해한 후 맴브레인 필터(membrane filter, 0.45 μm, pore size)로 여과, HPLC(Waters 2695 Separations Module, Waters Co., Milford, MA, USA)를 이용하여 측정하였으며, Symmetryⓡ C18(4.6×150 mm, 5㎛)컬럼(column)을 용매는 A(water)와 B(Acetonitrile)를 사용하였다. 이동상의 유속 1.0 ml/min, 컬럼 온도는 30℃로 하고, PDA 검출기의 검출 파장은 203 nm로 하여 분석하였다.
The composition and content of ginsenosides of the extract concentrate and the fermentation broth were determined by filtration through a membrane filter (0.45 μm, pore size), HPLC (Waters 2695 Separations Module, Waters Co., Milford, MA, USA) and Symmetry C18 (4.6 × 150 mm, 5 μm) column was used as a solvent and A (water) and B (Acetonitrile) were used as solvents. The flow rate of the mobile phase was 1.0 ml / min, the column temperature was 30 ° C, and the detection wavelength of the PDA detector was 203 nm.
2) 산양삼 유산균 발효에 의한 항산화 특성 및 특정 진세노사이드 증강 최적발효 조건 2) Antioxidative properties and fermentation conditions of specific ginsenosides by fermentation of L. acidophilus
(1) 분리 유산균주별 산양삼 추출물의 발효(1) fermentation of goat's ginseng extract by isolated lactic acid bacteria
산양삼의 발효는 1차로 증류수에 산양삼 농축액(25 °brix)을 5 중량 %를 첨가하여 121℃에서 15분으로 가압고온 멸균하여 실온 서서히 식힌 다음 미리 활성화 시킨 5종의 선발 균주를 접종하여 37℃에서 72시간 발효하여 발효특성을 조사하여 발효 활성이 가장 뛰어난 1종의 균주를 선택하였다.
The fermentation of goat's ginseng was carried out by firstly adding 5% by weight of concentrated soybean ginseng (25 ° brix) to distilled water, sterilized by pressurization at 121 ° C for 15 minutes, slowly cooled at room temperature, and then inoculated with five pre- After fermentation for 72 hours, fermentation characteristics were investigated and one strain with the best fermentation activity was selected.
(2) 산양삼 농도, 발효 시간 및 올리고당 농도의 설정(2) Setting the concentration of goat's ginseng, fermentation time and oligosaccharide concentration
산양삼의 발효조건을 설정하기 위하여 최적의 조건으로 추출한 산양삼 추출물을 감압농축시켜 25 브릭스로 조정한 다음 실험에 사용하였다. 반응표면분석법(response surface methodology)을 이용하였고, 발효조건에 대한 실험계획은 중심합성계획법을 실시하여 발효에 영향을 줄 것으로 고려되는 발효인자인 산양삼 농축 액 농도(X1), 발효시간(X2) 및 부원료 올리고당의 농도(X3)에 대한 시험범위를 설정하여 각각을 5단계로 부호화 것은 표 1과 같다. 중심합성계획에 따라 16구간으로 설정하여 발효실험을 하였다. 또한 이들 독립변수에 영향을 받는 종속변수(Yn)로는 적정산도(Y1), 젖산균수(Y2), 조사포닌 함량(Y3), 진세노사이드 함량(Y4) 및 항산화적 특성(Y5) 등을 측정하여 그 값을 회귀분석에 사용하였다. 또한 발효에 있어서 발효조건이 산양삼 발효물의 진세노사이드 유효성분 함량에 미치는 영향을 예측된 모델식을 바탕으로 Mathematica program을 이용하여 4차원 반응표면분석으로 해석하였다.
To determine the fermentation condition of goat ginseng, the extract of goat ginseng extracted under optimal conditions was concentrated under reduced pressure and adjusted to 25 bricks and used in the experiment. The response surface methodology was used and the experimental design for the fermentation conditions was carried out using the central synthetic design method to determine the concentrations (X1), fermentation times (X2) and The test range for the concentration (X3) of supplementary oligosaccharide is set, and the encoding is performed in five steps as shown in Table 1. The fermentation experiment was carried out with 16 sections according to the central synthesis plan. In addition, the dependent variable (Yn) affected by these independent variables was measured as the titratable acidity (Y1), lactic acid bacteria number (Y2), crude saponin content (Y3), ginsenoside content (Y4) and antioxidant properties (Y5) The values were used for regression analysis. The effect of fermentation conditions on the content of ginsenoside active ingredient in fermented soybean ginseng fermented product was analyzed by 4 - dimensional reaction surface analysis using Mathematica program based on the predicted model equation.
(3) 산양삼 발효물의 당도, pH 및 적정산도 측정(3) Measurement of sugar content, pH and titratable acidity of fermented soybean ginseng
발효 중 조건의 일정 시간별로 시료를 취하여 산양삼 발효물의 당도는 당도계(Refractometer, PR-201α, ATAGO, Japan)로 측정하였다. 산양삼 발효물의 pH는 pH meter(Metter Toledo Group, Switzerland)를 사용하여, 적정 산도는 0.1 N NaOH용액으로 pH 8.3으로 중화 적정하여 소비된 0.1 N NaOH용액을 젖산 함량(%)으로 환산하였다.
During fermentation, the samples were taken at fixed time intervals and the sugar content of fermented goat gums was measured with a refractometer (PR-201α, ATAGO, Japan). The pH of the fermented goat's ghana fermented product was converted to a lactic acid content (%) by using a pH meter (Metter Toledo Group, Switzerland) and titrating the titrated acidity with 0.1 N NaOH solution to pH 8.3.
(4) 산양삼 발효물의 생균수 측정(4) Measurement of viable count of fermented goat ginseng
산양삼 발효물의 생균수는 발효 중 일정 시간별로 시료를 무균적으로 취한 후 생리멸균식염수로 적정 희석하여 시판용 MRS 한천배지에 접종하여 37℃에서 24시간 배양 후 나타나는 콜로니 수로 나타내었다.
The number of viable cells of the fermented goat 's ginseng was determined by counting the number of colonies after incubation at 37 ° C. for 24 hours in a commercial MRS agar medium after the samples were aseptically taken during a certain period of time during fermentation and then diluted appropriately with physiological sterilized saline.
3) 산양삼 유산균 발효물의 항산화 특성3) Antioxidant properties of Fermented Lactic acid bacteria
(1) 전자공여능 측정(1) Electron donating ability measurement
산양삼 발효시료의 전자공여능은 α,α'-diphenyl-β-pycrylhydrazyl (DPPH)을 사용한 방법으로 측정하였다. 즉, DPPH 시약 12 mg을 무수에탄올 100 ml에 용해한 후 50% 에탄올용액을 첨가하여 DPPH 용액의 흡광도를 517 nm에서 약 1.0으로 조정한 후, 발효액 0.5 ml에 DPPH 용액 5 ml를 혼합하여 흡광도를 측정하였다.
The electron donating ability of the goat juice fermentation sample was measured by the method using α, α'-diphenyl-β-pycrylhydrazyl (DPPH). Namely, 12 mg of DPPH reagent was dissolved in 100 ml of anhydrous ethanol, and 50% ethanol solution was added to adjust the absorbance of the DPPH solution to about 1.0 at 517 nm. Then, 0.5 ml of the fermentation broth was mixed with 5 ml of DPPH solution Respectively.
(2) 총 페놀성 화합물 함량 측정(2) Measurement of total phenolic compound content
산양삼 발효시료의 폴리페놀 함량은 Folin-Denis 법에 의해 비색정량하였다. 시료 1 ml에 페놀시약(phenol reagent) 1 ml를 가하여 3분간 정치한 후 10% 탄산나트륨(Na2CO3) 1 ml를 혼합하고 1시간 실온에서 방치하여 700 nm에서 흡광도를 측정하였다. 표준곡선은 갈릭산(gallic acid) 용액으로 작성하였고, 총 페놀성 화합물 함량은 사용된 원료 양에 대한 백분율로 나타내었다.
Polyphenol content of goat juice fermented samples was determined by colorimetry by Folin-Denis method. 1 ml of phenol reagent was added to 1 ml of sample, and the mixture was allowed to stand for 3 minutes. 1 ml of 10% sodium carbonate (Na2CO3) was mixed and left at room temperature for 1 hour to measure the absorbance at 700 nm. The standard curve was prepared with a gallic acid solution and the total phenolic compound content was expressed as a percentage of the amount of raw material used.
(3) 2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid, ABTS) 라디칼 소거능(3) 2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid, ABTS)
ABTS 라디칼 소거능은 증류수에 녹인 7.2 mM ABTS 용액과 2.6 mM 과황산칼륨(potassium persulfate) 용액을 1:1로 혼합하여 12-16시간 동안 실온의 암소에서 방치한 후 메탄올(methanol)로 734 nm에서 흡광도가 1.1~1.2이 되도록 희석하였다. ABTS 희석용액 3.9 ml에 10.0 mg/ml의 농도로 조제한 시료 0.1 ml를 혼합한 다음 정확히 1분간 반응시킨 후 734 nm에서 흡광도를 측정하였다.
The ABTS radical scavenging activity was determined by mixing 7.2 mM ABTS solution dissolved in distilled water and 2.6 mM potassium persulfate solution in a ratio of 1: 1, allowing to stand at room temperature for 12-16 hours and then absorbance at 734 nm with methanol Was diluted to 1.1 to 1.2. 0.1 ml of the sample prepared at a concentration of 10.0 mg / ml was mixed with 3.9 ml of the ABTS dilution solution, reacted for exactly 1 minute, and the absorbance was measured at 734 nm.
(4) 아질산염 소거능 (4) Nitrite scavenging ability
산양삼 발효물 1 ml에 1 mM 아질산나트륨 용액 1 ml를 가하고 0.1 N HCl 및 0.1 M 구연산 완충액(pH 3.0)을 가하여 반응용액의 총 부피를 10 ml로 한 후 37℃에서 1시간 반응시켰다. 이 반응액 1 ml를 취하여 2% 초산용액과 Griess 시약을 차례로 가하여 520 nm에서 흡광도를 측정하여 시료 무첨가구에 대한 시료 첨가구의 아질산염 소거능을 계산하였다.
1 ml of 1 mM sodium nitrite solution was added to 1 ml of fermented goat's milk. 0.1 N HCl and 0.1 M citric acid buffer solution (pH 3.0) were added to make the total volume of the
실험예 1.Experimental Example 1
1. 유산균 선발1. Selection of lactic acid bacteria
1) 발효식품으로부터 유산균 분리1) Isolation of lactic acid bacteria from fermented food
발효 김치류 26종의 시료에서 단일콜로니로 분리된 균들 중, MRS 한천배지에서 유산균의 특징을 보이는 콜로니를 형태적으로 다른것을 분류하여 49개의 유산균을 순수 분리하였다. 49개의 유산균을 에스쿨린 한천법을 이용해 실험한 결과는 도 2 에 나타내었다. 27개의 유산균에서 콜로니 주위에 흑색반점(black complex)이 관찰되어 베타-글루코시데이즈(β-Glucosidase) 활성능이 있는 것으로 판단되었고, 에스쿨린의 반응을 보인 27개의 균주 중 17개는 흑색반점의 직경의 크기가 5mm 이하였고, 그중 반복실험을 통해 약 15mm이상의 흑색반점을 갖는 5개 균주를 분리하였다(표 3).
Of the 26 strains isolated from the fermented kimchi, 49 strains were isolated by morphologically differentiating colonies showing the characteristics of lactic acid bacteria on the MRS agar medium. The results of experiments of 49 lactic acid bacteria using the Esculin agar method are shown in Fig. Glucosidase activity was observed in 27 lactic acid bacteria around the colonies and 17 of the 27 strains reacted with Esculin were found to have black spot The size of the diameter was 5 mm or less, and five strains having black spots of about 15 mm or more were isolated through repeated experiments (Table 3).
2) 분리 균주의 베타-글루코시데이즈(β-Glucosidase) 활성능2) Beta-glucosidase activity of isolated strains
에스쿨린 반응에서 흑색반점의 직경이 15 mm이상으로 분리된 5종의 유산균을 대상으로 베타-글루코시데이즈 활성측정을 실시하였고, 이들 균주를 48시간 배양하여 베타글루코시데이즈 활성을 측정한 결과값은 표 4와 같다. 베타-글루코시데이즈 활성측정 결과 유산균 25번 균주가 배양시간 24시간에서 가장 높은 값을 나타내었다.
Beta-glucosidase activity was measured in 5 kinds of lactic acid bacteria having a black spot diameter of 15 mm or more in Escherichia reaction, and the activity of beta glucosidease activity was measured by culturing these strains for 48 hours Are shown in Table 4. Beta - glucosidase activity was the highest at 24 hours of incubation time.
3) 산양삼 발효를 위한 유산 균주선택3) Selection of lactic acid strains for fermentation of goat ginseng
산양삼 농축액을 10 브릭스로 희석 후 분리된 5종의 유산균주를 배양 접종하여 37℃에서 48 시간 배양하였다. 균주별 산양삼 발효물의 이화학적 성분 검사 결과는 표 5에 나타내었다. 성분 검사 결과, 5종의 균주 중 산 생성력과 산양삼 발효물내 유산균 생균수가 가장 높게 나타난 유산균 25번을 최종 발효유산균으로 선택하였다(도2).
The goat ginseng concentrate was diluted with 10 brix, and the five lactic acid bacteria isolated were inoculated and cultured at 37 ° C for 48 hours. The results of the physicochemical test for the fermented product of the goat ginseng according to the strain are shown in Table 5. As a result of the test, the lactic acid bacteria No. 25, which showed the highest acid production power and the highest number of lactic acid bacteria in the fermented product of the goat germ, was selected as the final fermented lactic acid bacteria (FIG. 2).
2. 분리유산균의 동정2. Identification of isolated lactic acid bacteria
최종 선택된 균주 중 활성능이 가장 높은 25번 균주의 16S rRNA gene의 부분 염기서열을 분석하여 NCBI blast DB와 비교한 결과는 표 6과 같다. 그 결과 데이터베이스의 비교균주로 Leuconostoc mesenteroides strain ATCC 8293 등 Leuconostoc mesenteroides의 균주와 99%의 유사성을 보였다. 그리고 상기 데이터베이스 연관균주와 분리균주의 16S rRNA 유전자 시퀸스 기반으로 한 계통수(phylogenetic tree)의 근연관계도는 도 3과 같다. 이들의 결과를 근거로 최종분리된 균주를 Leuconostoc mesenteroides으로 동정하고 Leuconostoc mesenteroides DU-B1604로 최종 명명하였으며 본 균주를 한국생명공학연구원 생물자원센터에 특허 기탁하여 2016.4.25자 기탁번호 KCTC 13015BP를 부여받았다.
The partial sequence of the 16S rRNA gene of the 25th strain with the highest activity among the finally selected strains was analyzed and compared with the NCBI blast DB. As a result, it showed 99% similarity with the strain of Leuconostoc mesenteroides such as Leuconostoc mesenteroides strain
실험예 2. 산양삼 추출 농축액을 활용한 젖산균 발효조건의 최적화Experimental Example 2. Optimization of Fermentation Conditions of Lactic Acid Bacteria Using Concentrated Goat Yeast Extract
1) 부원료 올리고당 첨가효과 조사1) Effect of supplementary oligosaccharide addition
부원료로서 올리고당의 첨가가 산양삼의 젖산균의 발효에 미치는 영향을 조사하기 위해 산양삼 농축액(25브릭스) 5 중량%에 각종 올리고당의 종류를 각각 1 중량%를 첨가한 후 분리 유산균 Leuconostoc mesenteroides DU-B1604을 접종하여 37℃에서 48시간 발효하여 생균수, pH 및 산도 등을 조사한 결과는 표 7과 같다. 발효 후 pH는 갈락토올리고당이 3.66으로 가장 낮게 나타났으며, 이소말토올리고당은 pH 4.70으로 가장 높게 나타났다. 산도는 갈락토올리고당이 0.50%로 가장 높게 나타나 산 생성력이 가장 높았으며 이소말토올리고당은 0.34로 가장 낮은 증가를 보였다. 유산균수는 초기 107의 접종량에서 발효후 대부분 1010으로 증가하여 유산균의 생육에 올리고당의 첨가가 유효하였고 특히 갈락토올리고당이 7.90 x 1010으로 가장 많은 균수를 나타났다. 따라서 산양삼의 유산균 발효에 부원료로서 갈락토올리고당이 가장 유효한 것으로 나타났다.To investigate the effect of the addition of oligosaccharide as a raw material on the fermentation of lactic acid bacteria in the goat ginseng, 1 wt% of various oligosaccharides were added to 5 wt% of a concentrated goat gum (25 BRICKS), and then inoculated with the isolated lactic acid bacteria Leuconostoc mesenteroides DU-B1604 And the fermentation was carried out at 37 DEG C for 48 hours, and the viable cell count, pH and acidity were examined. After fermentation, galactooligosaccharide was lowest at 3.66 and isomaltooligosaccharide was the highest at pH 4.70. The highest acidity was obtained with 0.50% of galacto - oligosaccharides and the lowest with 0.34 of isomaltooligosaccharides. The number of lactic acid bacteria was increased to 1010 after fermentation at the initial dose of 107, and the addition of oligosaccharide to the growth of lactic acid bacteria was effective. Especially, the number of galacto - oligosaccharides was 7.90 × 1010, Therefore, galactooligosaccharide was most effective as a supplement to lactic acid bacteria fermentation of goat ginseng.
2) 발효조건에 따른 산양삼 추출물의 발효 특성 모니터링2) Monitoring fermentation characteristics of goat juice extract according to fermentation condition
분리유산균 Leuconostoc mesenteroides DU-B1604에 의한 산양삼 추출물의 유산균 최적발효조건을 설정하기 위해 산양삼 첨가농도, 발효시간 및 부원료인 갈락토올리고당 농도를 독립변수로 하여 중심합성계획에 의해 설계된 16구의 발효조건에서 얻어진 pH, 산도 및 유산균수의 결과는 표 8과 같다. 산양삼 발효액의 pH는 3.43∼3.73, 총산도는 0.37∼0.80%, 유산균수는 12.29∼14.81 Log CFU/ml 및 조사포닌 함량은 0.06∼0.34%를 나타내어 산양삼 농도, 발효시간 및 부원료 농도에 따른 차이를 보여주었다.
In order to establish the optimal fermentation conditions for the extract of L. acidophilus L. lactobacillus Leuconostoc mesenteroides DU-B1604, the fermentation conditions of sixteen sows, designed by the central synthesis program, were used as independent variables for the concentration of goat juice added, fermentation time and sub- The results of pH, acidity and number of lactic acid bacteria are shown in Table 8. The pH and total acidity of the fermented goat ginseng were 3.43 ~ 3.73, 0.37 ~ 0.80%, respectively, and the log CFU / ml and crude saponin content were 0.06 ~ 0.34%, respectively. .
각각의 결과를 이용한 반응표면 회귀분석을 실시하고 각 종속변수 즉, pH, 산도, 유산균수 및 조사포닌 함량에 대한 회귀 다항식을 얻어 표 9에 나타내었다. 산양삼의 발효조건에 따른 발효 특성의 다항식의 R2는 pH 0.8221, 총산도 0.9682, 유산균수 0.8608 및 조사포닌 함량은 0.8595의 상관관계를 나타내었다. 한편 pH의 경우 다항식이 10% 이내의 유의성이 인정되었으며, 유산균수 및 조사포닌 함량의 다항식은 5% 이내의 유의성이 인정되는 것으로 나타났으며, 총산도의 다항식은 1% 이외로 유의성이 인정되는 것으로 나타났다.
The reaction surface regression analysis using each result was performed and regression polynomials for each dependent variable, namely, pH, acidity, number of lactic acid bacteria and crude saponin content, were obtained and shown in Table 9. The R2 of the fermentation characteristics according to the fermentation condition of the goat ginseng showed a correlation of pH 0.8221, total acidity 0.9682, lactic acid bacteria number 0.8608 and crude saponin content 0.8595. On the other hand, in case of pH, polynomials were recognized to have significance within 10%, polynomials of lactic acid bacteria and crude saponin contents were found to be within 5%, and polynomials of total acidity were considered to be significant except 1% Respectively.
pH
pH
산양삼의 발효조건에 따른 발효 특성에 대한 다항식을 바탕으로 도 4∼7과 같은 4차원 반응표면 그래프를 확인할 수 있다. 발효액의 pH와 총산도의 경우 부원료의 농도가 증가하고, 발효시간이 길어질수록 pH 값은 낮은 경향을 보였으며, 총산도는 높은 함량을 나타내었다. 또한 유산균수는 산양삼 농도가 4.5∼5.5% 범위에서 발효시간이 높은 값을 나타내었다.
Based on the polynomial equation for the fermentation characteristics according to the fermentation conditions of goat ginseng, a four-dimensional reaction surface graph as shown in FIGS. 4 to 7 can be confirmed. The pH and total acidity of the fermentation broth increased as the concentration of the submaterial increased, and as the fermentation time increased, the pH value tended to be lower and the total acidity was higher. The fermentation time of lactic acid bacteria was in the range of 4.5 ~ 5.5%.
산양삼의 유산균발효에서 조건의 반응변수에 따른 영향은 표 10과 같다. pH는 부원료 농도에서 5% 이내의 유의성이 인정되었으나, 산양삼 농도와 발효 시간에서는 영향을 받지 않는 것으로 나타났으며, 총산도의 경우 부원료 농도에서 가장 큰 영향을 받고 있는 것으로 나타났으며, 발효시간에서는 5% 이내의 유의성이 인정되었다. 또한 유산균수는 발효시간에서 5% 이내의 유의성이 인정되었으나, 나머지 두 조건에서는 범위 내에서 영향을 받지 않은 것으로 나타났다. 조사포닌 함량의 경우는 산양삼 농도에 가장 큰 영향을 받는 것으로 나타났으며, 나머지 두 조건에서는 거의 영향을 받지 않는 것으로 나타났다.
Table 10 shows the effect of the response variables on the lactic acid fermentation of goat ginseng. The pH value was found to be within 5% of the sub - ingredient concentration but was not affected by the concentration of goat 's ginseng and the fermentation time. The total acidity was found to be most influenced by the sub ingredient concentration. The significance within 5% was recognized. The number of lactic acid bacteria was within 5% of the fermentation time, but it was not affected by the other two conditions. The crude saponin content was found to be the most influenced by the concentration of goat juice and was not affected by the other two conditions.
산양삼 발효 결과에 대한 능선분석을 통해 표 11과 같은 발효특성의 최대조건 및 최대값을 예측하였다. pH는 산양삼 농도 5.04% 발효시간 69.09 시간, 갈락토올리고당 농도 1.90% 조건에서 안장점의 형태였고, 총산도는 산양삼 농도 5.26%, 발효시간 68.44, 갈락토올리고당 농도 1.90% 조건에서 안장점 형태였으며, 유산균수는 산양삼 농도 4.90% 발효시간 89.84 hr, 갈락토올리고당 농도 1.07% 조건에서 최대점 형태이었고 조사포닌 함량은 산양삼 농도 9.05%, 발효시간 42.00 hr, 부원료 농도 0.79% 조건에서 최대점이었다. 또한 각각의 최댓값 3.37, 0.87%, 14.20 Log CFU/ml 및 0.32%로 예측되었다.
The maximum conditions and maximum values of the fermentation characteristics as shown in Table 11 were predicted by ridge analysis of the results of the fermentation of goat ginseng. The pH was in the form of ginseng under the condition of the ginseng concentration 5.04%, the fermentation time 69.09 hours and the galactooligosaccharide concentration 1.90%. The total acidity of the ginseng was 5.26%, the fermentation time 68.44 and the galactooligosaccharide concentration 1.90% The maximum number of lactic acid bacteria was 4.9% in the ginseng concentration, 89.84 hr in the fermentation time and 1.07% in the galactooligosaccharide concentration. The crude saponin content was the highest at 9.05% of the ginseng concentration, 42.00 hr of fermentation time and 0.79% of the additive concentration. Also, the maximum values were estimated to be 3.37, 0.87%, 14.20 Log CFU / ml and 0.32%, respectively.
3) 발효조건에 따른 산양삼의 항산화적 특성 모니터링3) Monitoring of antioxidant properties of goatsam according to fermentation conditions
분리균주 Leuconostoc mesenteroides DU-B1604 균주를 이용하여 중심합성계획에 의한 16구간으로 산양삼 유산발효물의 항산화적 특성을 모니터링한 결과는 표 12와 같다. 산양삼 유산균 발효액의 총 페놀성 화합물 함량은 41.53∼69.97 mg%, DPPH 라디칼 소거능은 52.26∼70.14%, ABTS 라디칼 소거능은 26.99∼50.44, 아질산염 소거능은 16.81∼32.57% 범위를 나타내어 산양삼 농도, 발효시간 및 부원료 농도에 따른 차이를 보여주었다.
The antioxidative properties of the fermented goat yams were investigated by using 16 isolates of Leuconostoc mesenteroides DU-B1604. The total phenolic compounds content of the fermented Lactobacillus acidic L. acidus was 41.53 ~ 69.97 mg%, DPPH radical scavenging activity was 52.26 ~ 70.14%, ABTS radical scavenging activity was 26.99 ~ 50.44 and nitrite scavenging activity was 16.81 ~ 32.57% And showed the difference according to the concentration.
산양삼 유산발효액의 발효조건에 따른 각 항산화적 특성에 대한 다항식은 표 13과 같다. 다항식의 R2는 총 페놀성 화합물 함량 0.9929, DPPH 라디칼 소거능은 0.9063, ABTS 라디칼 소거능 0.8541, 아질산염소거능 0.9853로 모두 비교적 높은 상관관계를 나타내었다. 한편 총 페놀성 화합물 함량, DPPH 라디칼 소거능과 아질산염 소거능은 1% 이내의 유의성이 인정되었고, 조사포닌 함량과 ABTS 라디칼 소거능의 경우는 5% 이내의 유의성이 인정되는 것으로 나타났다.
Table 13 shows the polynomials for each antioxidant property of fermented soybean milk fermentation broth according to fermentation conditions. The R2 of the polynomials showed a relatively high correlation with total phenolic compound content of 0.9929, DPPH radical scavenging activity of 0.9063, ABTS radical scavenging activity of 0.8541 and nitrite scavenging activity of 0.9853. The contents of total phenolic compounds, DPPH radical scavenging activity and nitrite scavenging activity were within 1%, and crude saponin content and ABTS radical scavenging activity were within 5%.
산양삼의 유산균발효조건에 따른 표 13의 항산화적 특성에 대한 다항식을 바탕으로 도 8∼11와 같은 4차원 반응표면 그래프를 확인할 수 있었다. 산양삼의 발효에 따른 항산화적 특성은 산양삼 농도에 대한 영향을 많이 받는 경향을 보여주어, 산양삼 농도가 증가할수록 그 값들이 증가하는 것으로 나타났다.
Based on the polynomial equation for the antioxidant properties of Table 13 according to fermentation conditions of lactic acid bacteria of goat ginseng, a four-dimensional reaction surface graph as shown in Figs. 8 to 11 was obtained. The antioxidative properties of goat ginseng showed a tendency to be affected by the concentration of goat ginseng and increased with increasing concentration of goat ginseng.
산양삼의 발효에서 조건변수에 따른 영향은 표 14와 같다. 총 페놀성 화합물 함량의 경우 산양삼 농도에서 1% 이내, 발효시간에서 10% 이내에서 유의성이 인정되었으며, DPPH 라디컬 소거능, ABTS 라디컬 소거능과 아질산염 소거능은 산양삼 농도에서 1∼5% 이내의 유의성이 인정되었으나, 나머지 두 조건에서는 범위 내에서 영향을 받지 않는 것으로 나탔다.
Table 14 shows the effect of condition variables on the fermentation of goat ginseng. The DPPH radical scavenging ability, ABTS radical scavenging ability and nitrite scavenging ability were within 1 ~ 5% in the concentration of goat juice. But not in the range of the other two conditions.
산양삼의 발효결과에 대한 능선분석을 통해 표 15와 같은 발효의 최적조건 및 최댓값을 예측하였다. 그 결과 총 페놀성 화합물 함량은 산양삼 농도 9.52%, 발효시간 36.75 hr, 갈락토올리고당 농도 0.52% 조건에서, DPPH 라디칼 소거능은 산양삼 농도 8.08%, 발효시간 43.41 hr, 갈락토올리고당 농도 0.91% 조건에서, ABTS, 라디칼 소거능은 산양삼 농도 9.00%, 발효시간 40.47hr, 갈락토올리고당 농도 0.79% 조건에서, 아질산염 소거능은 산양삼 농도 9.66%, 발효시간 57.20 hr, 갈락토올리고당 농도 0.55% 조건에서 각각의 최댓값 81.57 mg%, 64.81%, 63.44% 및 52.36%을 예측되었다.
The optimum conditions and the maximum value of the fermentation as shown in Table 15 were predicted through ridge analysis of the fermentation result of goat ginseng. As a result, the DPPH radical scavenging activity was found to be 8.08%, the fermentation time was 43.41 hr, the galactooligosaccharide concentration was 0.91%, the total phenolic compound content was 9.52%, the fermentation time was 36.75 hr and the galactooligosaccharide concentration was 0.52% The nitrite scavenging activity of ABTS was 9.75%, the fermentation time was 57.20 hr and the galactooligosaccharide concentration was 0.55%. The nitrite scavenging activity was the highest at 81.57 mg %, 64.81%, 63.44% and 52.36%, respectively.
산양삼의 최적의 유산균발효에 의하여 조사포닌, 총페놀성 화합물 함량과 DPPH 라디컬 소거능 등이 모두 높은 최적 조건을 설정하기 위하여 도 12와 같이 각 반응표면을 다중겹침(superimposing)한 결과, 발효조건은 산양삼 농축액 (25브릭스)농도 8∼9 중량%, 발효시간 35∼45 시간 및 갈락토올리고당 농도 0.6∼0.9%로 예측되었다. 이들 예측조건에서 실제 발효전, 후의 항산화 특성값을 측정한 결과는 표 16과 같다. 항산화적 특성값이 발효전에 비하여 발효후 60.67~165.20%의 증가를 보여 발효에 의하여 항산화적 특성값이 증강됨을 보였다.
As a result of superimposing each reaction surface as shown in FIG. 12 in order to set optimum conditions for crude saponin, total phenolic compound content and DPPH radical scavenging ability by optimum lactic acid fermentation of goat ginseng, It was predicted that the concentration of goat's ghrelin concentrate (25 brix) was 8 to 9 wt%, the fermentation time was 35 to 45 hours, and the concentration of galactooligosaccharide was 0.6 to 0.9%. Table 16 shows the antioxidant properties before and after fermentation. The antioxidant properties were increased by 60.67 ~ 165.20% after fermentation, indicating that the antioxidant properties were enhanced by fermentation.
4) 발효조건에 따른 산양삼의 진세노사이드 함량 변화 모니터링4) Monitoring the change of ginsenoside content of goatsam according to fermentation condition
산양삼 추출 농축액을 이용하여 중심합성계획에 의한 16구간을 분리균주 Leuconostoc mesenteroides DU-B1604 균주로 발효 후 발효시료의 진세노사이드 화합물 함량을 측정한 결과는 표 17과 같다. 산양삼 발효액의 진세노사이드 Rg1 함량은 1.757.21 mg%, 진세노사이드 Rb1 함량은 6.5322.81 mg%, 진세노사이드 Rh1 함량은 1.273.76 mg%, 진세노사이드 Rg3 함량은2.915.33 mg%, 진세노사이드 컴파운드 K 함량은 3.568.30 mg% 나타내어 산양삼 농도, 발효시간 및 부원료 농도에 따른 차이를 나타내었다.
Sixteen strains were isolated by centrifugation using the extract of goat extract Leuconostoc mesenteroides The content of ginsenoside compounds in the fermented samples after fermentation with DU-B1604 was measured, and the results are shown in Table 17. The ginsenoside Rg 1 content of the goat's fermentation broth was 1.757.21 mg%, the ginsenoside Rb 1 content was 6.5322.81 mg%, the ginsenoside Rh 1 content was 1.273.76 mg%, the ginsenoside Rg 3 content was 2.915 . The content of ginsenoside compound K was 3.568.30 mg%, indicating the difference according to the concentration of goat juice, fermentation time and additive concentration.
* Control : 산양삼 농도 5% 시료의 발효전 gensenoside 함량
* Control: ginsenoside content before fermentation of 5% sample of goat's ginseng
산양삼의 발효조건에 따른 진세노사이드 화합물 함량 변화에 대한 다항식은 표 18과 같다. 다항식의 R2는 진세노사이드 Rg1 함량 0.8483, 진세노사이드 Rb1 함량은 0.8487, 진세노사이드 Rh1 함량은 0.8455, 진세노사이드 Rg3 함량은 0.8415, 진세노사이드 compound K 함량은 0.9225로 모두 높은 상관관계를 나타내었다. 한편 진세노사이드 compound K 함량은 1% 이내의 수준에서 진세노사이드 Rg1, 진세노사이드 Rb1 , 진세노사이드 Rh1 및 진세노사이드 Rg3 함량은 10% 이내의 수준에서 각각의 유의성이 인정되었다.
Table 18 shows the polynomials for the change in ginsenoside content according to the fermentation conditions of goat ginseng. R 2 of the polynomial equation is 0.8483 for ginsenoside Rg 1 , 0.8487 for ginsenoside Rb 1 , 0.8455 for ginsenoside Rh 1 , 0.8415 for ginsenoside Rg 3 and 0.9225 for ginsenoside compound K Respectively. On the other hand, the content of ginsenoside compound K is lower than 1% at the level of ginsenoside Rg 1 , ginsenoside Rb 1 , ginsenoside Rh 1 and ginsenoside Rg 3 The contents were within the range of 10%.
산양삼의 발효조건에 따른 표 18의 진세노사이드 화합물 함량에 대한 다항식을 바탕으로 도 1317와 같은 4차원 반응표면 그래프를 확인할 수 있었다. 발효액의 진세노사이드 화합물 함량은 산양삼 농도와 발효시간에 영향을 많이 받아 산양삼 농도가 높고 발효시간이 길수록 증가하는 경향을 보여주었다.
Based on the polynomial equation for the ginsenoside content in Table 18 according to the fermentation conditions of the goat ginseng, a four-dimensional reaction surface graph as shown in Figure 1317 was obtained. The content of ginsenoside in the fermentation broth was affected by the concentration of goat ginseng and the fermentation time and showed a tendency to increase with increasing concentration of goat 's ginseng and longer fermentation time.
산양삼의 발효에서 조건변수에 따른 영향은 표 19와 같다. 진세노사이드 Rg1과 Rb1은 특히 산양삼 농도에 대한 영향이 큰 것으로 나타났으며, 나머지 두 조건에서는 영향을 받지 않는 것으로 나타났고, 진세노사이드 Rh1은 산양삼 농도, 발효시간 순으로 영향을 받는 것으로 나타났으며, 설정된 범위 내에서 갈락토올리고당 농도에 대한 영향은 거의 없는 것으로 나탔다. 또한 진세노사이드 Rg3 함량은 산양삼 농도, 갈락토올리고당 농도 순으로 영향을 받는 것으로 나타났으며, 설정된 범위 내에서 발효시간에 대한 영향은 받지 않는 것으로 나타났다. Compound K의 함량은 세 가지 조건 모두에서 영향을 받고 있는 것으로 나타났다.
Table 19 shows the effect of condition variables on the fermentation of goat ginseng. Ginsenosides Rg 1 and Rb 1 were found to have a large effect on the concentration of goat ginseng and were not affected by the other two conditions. Ginsenoside Rh 1 was affected by the concentration of goat ginseng and fermentation time And there was little effect on the concentration of galactooligosaccharide within the set range. Also, ginsenoside Rg 3 The contents were affected by the order of goat juice concentration and galactooligosaccharide concentration, and the effect of fermentation time was not affected within the set range. The content of Compound K was affected by all three conditions.
*Significant at 10% level; **significant at 5% level; ***significant at 1% level.
* Significant at 10% level; ** significant at 5% level; *** significant at 1% level.
산양삼의 발효 결과에 대한 능선분석을 통해 표 20과 같은 발효의 최적건 및 최댓값을 예측하였다. 진세노사이드 Rg1 함량 산양삼 농도 9.65%, 발효시간 49.78 hr, 갈락토올리고당 농도 0.69% 조건에서, 진세노사이드 Rb1 함량은 산양삼 농도 9.15%, 발효시간 62.66 hr, 갈락토올리고당 농도 0.54% 조건에서, 진세노사이드 Rh1 함량은 산양삼 농도 8.02%, 발효시간 53.01 hr, 갈락토올리고당 농도 0.91% 조건에서, 진세노사이드 Rg3 함량은 산양삼 농도 8.44%, 발효시간 60.66 hr, 갈락토올리고당 농도 0.79% 조건에서, 진세노사이드 컴파운드 K 함량은 산양삼 농도 6.39%, 발효시간 58.89 hr, 갈락토올리고당 농도 0.94% 조건에서 각각의 최댓값으로 Rg1 6.83 mg%, Rb1 22.31 mg%L, Rh1 3.96 mg%, Rg3 5.45 mg% 및 컴파운드 K 6.64 mg%로 예측되었다. 이 예측값은 표 17의 발효전 시료의 진세노사이드 함량을 비교한 결과는 표 21과 같다. Rg1은 1.52배, Rb1은 1.30배로 소량 중가 하였지만 Rh1은 5.42배, Rg3는 14.34배 및 컴파운드 K는 94.86배 증가하여 최적 발효 조건에서 발효할 경우 특정의 진세노사이드인 Rh1 , Rg3 및 컴파운드 K의 함량의 증강이 일어나는 것을 알 수 있다.
The optimum ratios and maximum values of fermentation as shown in Table 20 were predicted through ridge analysis of the fermentation results of goat ginseng. It lost the ginsenoside Rg 1 content sanyangsam concentration of 9.65%, the fermentation time 49.78 hr, galacto-oligosaccharide concentration 0.69% condition, ginsenoside Rb 1 content sanyangsam concentration of 9.15%, the fermentation time 62.66 hr, galacto-oligosaccharide concentration in the 0.54% Conditions , ginsenoside Rh 1 content sanyangsam concentration of 8.02%, the fermentation time 53.01 hr, in galacto-oligosaccharide concentration 0.91% condition, ginsenoside Rg 3 content sanyangsam concentration of 8.44%, the fermentation time 60.66 hr, galacto-oligosaccharide concentration 0.79% in the condition, ginsenoside compound K content sanyangsam concentration 6.39%, the fermentation time 58.89 hr, the galacto-oligosaccharide concentrations, respectively of 0.94% at the maximum value condition Rg 1 6.83 mg%, Rb 1 22.31 mg% L, Rh 1 3.96 mg%, Rg 3 5.45 mg% and compound K 6.64 mg%. The predicted values of the ginsenosides of the samples before fermentation in Table 17 are shown in Table 21. Rg 1 increased by 1.52 times and Rb 1 increased by 1.30 times. However, Rh 1 increased 5.42 times, Rg 3 increased 14.34 times, and compound K increased 94.86 times. When fermenting under optimal fermentation conditions, Rh 1 and Rg 3 and the compound K are increased.
산양삼의 최적의 유산균 발효조건을 설정하기 위하여 진세노사이드 Rh1, Rg3 및 compound K 함량이 모두 최대를 이루는 최적 조건을 설정하기 위하여 도 18과 같이 각 반응표면을 디중겹침(superimpse)한 결과, 발효조건은 표 22에서와 같이 산양삼 농도 68%, 발효시간 5565 시간 및 부원료 농도 0.50.8%로 예측되었다. 이들 예측된 최적발효조건에서 발효전(도 18)과 발효후의 진세노사이드를 분석한 크로마토 그램은 도 19과 같다.
In order to set optimal conditions for lactic acid bacteria fermentation of goat's ginseng, each reaction surface was superimposed on each reaction surface as shown in FIG. 18 in order to set the optimum conditions for maximizing the contents of ginsenosides Rh 1 , Rg 3 and compound K, As shown in Table 22, the fermentation conditions were predicted to be 68% of goat juice concentration, 5565 hours of fermentation time and 0.50.8% of additive concentration. FIG. 19 shows the chromatogram obtained before the fermentation (FIG. 18) and after the fermentation of the ginsenoside in these predicted optimal fermentation conditions.
본 발명은 Leucomostic 속 균주 DUB1604를 이용하여 항산화효능과 특정 진세노이드 Rg3, Rh1 및 Compound K 함량이 강화된 산양삼 발효물을 제공하는 효과가 있으므로 건강 기능성 식품산업상 매우 유용한 발명인 것이다.
The present invention is an extremely useful invention in the health functional food industry because it provides an antioxidant effect and a specific ginsenoside Rg 3 , Rh 1 and Compound K content enhanced lean crude ginseng fermented product using Leucomostic genus DUB 1604.
Claims (7)
A first step (S1) of concentrating the goat's ginseng extract; A second step (S2) of adjusting the goat's ghe concentrate obtained in the above step to 1 to 50% by volume of the total volume; A third step (S3) of adding 0.1 to 30% by volume of galactooligosaccharide to the total volume of the adjustment solution obtained in the above step, adjusting the pH to 5.0 to 7.0, and sterilizing the solution; The leuconostoc mesenteroides DU-B1604 (KCTC 13015BP), which was pre-cultured in a commercially available MRS medium, was inoculated into the soymilk composition obtained by sterilizing in the above step, Step S4; The fifth step (S5) of fermenting the composition liquid obtained by inoculating the lactic acid bacterium obtained in the above step at a fermentation temperature of 20 to 45 ° C and a fermentation time of 6 to 120 hours and having an antioxidative activity and containing ginsenosides Rg 3 , Rh 1 and compound K Wherein the content of the lactic acid bacteria is increased.
[6] The method of claim 1, further comprising a sixth step of sterilizing the fermented goat gum obtained in the fifth step at a sterilization temperature of 60 to 100 DEG C for 10 to 60 minutes, filtering the microorganism through a microfilter filter Wherein the fermented product is a fermented product.
[Claim 2] The method according to claim 1, wherein the liquid goat ginseng obtained in the first step is selected from at least one selected from the group consisting of a ginseng root liquor, a goat ginseng extract, a goat ginseng concentrate, a dried goat ginseng product, and a goat ginseng granule.
The method according to claim 1, wherein the galactooligosaccharide in step (3) is prepared by selecting at least one selected from maltooligosaccharide, fructooligosaccharide, and isomaltooligosaccharide Wherein the fermented product is a fermented product.
The method of claim 2, wherein the fermentation product obtained in the fifth step or the sterilization filtration fermentation product obtained in the sixth step is 0.1 ~ 99.9 wt% or an apple, persimmon, blueberry, blackberry, black currant, Pomegranate, grape, pear, peach, banana, strawberry, tomato, carrot, plum, plum, cherry, A raw material fruit made of mango, lemon, pineapple or a juice or a concentrate thereof is added in an amount of 0.1 to 99.9 parts by weight or as part of a skin.
A fermented product of lactic acid bacteria of the goat ginseng having antioxidant activity produced by the method of any one of claims 1 to 5, wherein the content of ginsenosides Rg 3 , Rh 1 and compound K is enhanced.
A health-functional food composition comprising the fermented product of Lactobacillusthus sinensis having the antioxidant activity of claim 6 and having enhanced content of ginsenosides Rg 3 , Rh 1, and Compound K as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160069877A KR101882468B1 (en) | 2016-06-03 | 2016-06-03 | THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160069877A KR101882468B1 (en) | 2016-06-03 | 2016-06-03 | THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170137566A true KR20170137566A (en) | 2017-12-13 |
KR101882468B1 KR101882468B1 (en) | 2018-07-27 |
Family
ID=60944620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160069877A KR101882468B1 (en) | 2016-06-03 | 2016-06-03 | THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101882468B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102094084B1 (en) * | 2018-10-30 | 2020-03-26 | 경남과학기술대학교 산학협력단 | Aged and complex-fermented mountain-cultivated ginseng having increased ginsenosides of human body absorption type and omega-6 fatty acid, and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120061189A (en) * | 2010-12-03 | 2012-06-13 | 천지영농조합법인 | Fermented tea using wood-cultivated ginseng, and manufacturing method thereof |
-
2016
- 2016-06-03 KR KR1020160069877A patent/KR101882468B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120061189A (en) * | 2010-12-03 | 2012-06-13 | 천지영농조합법인 | Fermented tea using wood-cultivated ginseng, and manufacturing method thereof |
Non-Patent Citations (2)
Title |
---|
Zhongmei He 외 9명, ‘Antioxidant activity of prebiotic ginseng polysaccharides combined with potential probiotic Lactobacillus plantarum C88’, International Journal of Food Science and Technology 제50권제 * |
박수지 외 3명, ‘Whole Cell Biotransformation of Major Ginsenosides Using Leuconostocs and Lactobacilli’, Food science and biotechnology 제21권제3호, 839-844쪽, 2012년 06월. * |
Also Published As
Publication number | Publication date |
---|---|
KR101882468B1 (en) | 2018-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101402031B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 | |
KR102403798B1 (en) | Fermented broth comprising ginsenoside originated the leaf of ginseng and manufacturing method thereof | |
KR100943024B1 (en) | Bokbunja Rubus coreanus Miq. vinegar and its preparation method | |
KR20180019283A (en) | Wine and vinegar with high taste and flavor and functionality from mixtures of kiwi-fruit, persimmon and wild grapes, and preparation method thereof | |
KR101616187B1 (en) | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus | |
KR101913004B1 (en) | Manufacturing method of fermented mulberry beverage using mycelia of chaga mushroom | |
KR20150070933A (en) | The manufacturing method of mulberry solution having antioxidant functional fermented by lactic acid bacteria | |
KR101882468B1 (en) | THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA | |
KR101238067B1 (en) | Pear jam composition comprising fermented materials using lactic acid bacteria, and the preparation method thereof | |
KR102000286B1 (en) | Method for producing fermented barley sprout with enhanced saponarin, isovitexin and luteolin using novel Lactobacillus fermentum strain | |
KR101903633B1 (en) | Method for producing fermented Allium hookeri using blueberry solution fermented by lactic acid bacteria | |
KR20230129136A (en) | Composition for antibacterial, antioxidant, or anti-inflammatory comprising fermented extracts of Canavalia gladiata leaf as an active ingredient | |
KR101814941B1 (en) | Food composition for anti-oxidation comprising cockscomb flower extract short-term fermented by lactic acid bacteria and the method of preparation thereof | |
KR100651248B1 (en) | A preparation method of beverages, jam and sauce for softening meat using immature fruit and mature fruit of BOKBOONJA | |
KR102078178B1 (en) | Method for manufacturing composition using wood-cultivated ginseng and Schisandra chinensis, and composition manufactured by the same | |
KR20230022672A (en) | Novel traditional vinegar-derived strains and uses thereof | |
KR20130077911A (en) | Functional food prepared from bamboo sprout vinegar and process for preparing thereof | |
KR102030902B1 (en) | Fermentation method of lactic acid bacteria using fruit of Prunus sp. and its use | |
KR20030000078A (en) | Waterm elon wine using saccharomyces sp. kws06 and method for the preparation of it | |
KR101924392B1 (en) | Method for Preparing Yogurt and the Yogurt Obtained Thereby | |
KR20090061114A (en) | Health functional chrysanthemun vinegar ane process for preparation thereof | |
KR20160095738A (en) | Functional food comprising Dendropanax morbifera Lev. fermentation vinegar and process for preparing the same | |
KR101494165B1 (en) | Method for preparing Makgeolli added with Akebia quinata and Rice Makgeolli manufactured by this method | |
KR102464621B1 (en) | Manufacturing for functional vinegar using tricolor tangerine and acetobacter pasteurianus jb202002 | |
KR102457478B1 (en) | Broccoli Sprouts Fermentation Composition with Enhanced Sulforaphane and Quercetin using Pediococcus acidilactici DU. LAB. K-1(KCTC 13963BP) of novel lactic acid bacteria and Manufacturing Method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |